{"entity":{"id":"nct05879068","kind":"trial","name":"A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC","aka":[],"tldr":"A phase 2 trial of PM8002 in small-cell lung cancer, run by Biotheus Inc., active and no longer recruiting.","summary":"A Study of PM8002 in Combination With Chemotherapy in Patients With SCLC is a phase 2 interventional study registered as NCT05879068 by Biotheus Inc., with 99 participants enrolled, started 2022-05-27 and due to reach its primary completion in 2025-04-30. Interventions recorded: PM8002 and Paclitaxel.","status":"active","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT05879068","url":"https://clinicaltrials.gov/study/NCT05879068"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["sclc"],"sections":[],"technologies":[],"targets":[],"drugs":["pm8002"],"companies":["biontech"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT05879068","phase":"2","setting":"A Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of PM8002 Injection in Combination With Paclitaxel Injection as Second Line Treatment for Small Cell Lung Cancer(SCLC)","sponsor":"Biotheus Inc.","enrolled":99,"outcomes":[]},"route":"/trials/nct05879068/","neighbours":{"cancer":[{"id":"sclc","kind":"cancer","name":"Small-cell lung cancer","route":"/cancers/sclc/"}],"drug":[{"id":"pm8002","kind":"drug","name":"PM8002","route":"/drugs/pm8002/"}],"company":[{"id":"biontech","kind":"company","name":"BioNTech","route":"/companies/biontech/"}]}}